Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

ConditionsAortic Aneurysm and Dissection Cardiac Valve Disease Thoracic Aortic Aneurysm Thoracic Aortic Dissection

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-75

SponsorPetrovsky National Research Centre of Surgery

About this trial

According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Ampicillin-sulbactam

Treatment groups

50 Participants

are divided into 2 treatment groups

Locations

Petrovsky Research National Centre of Surgery (Petrovsky NRCS)119991, MoscowMoscow, Russia

Sponsors and collaborators

Petrovsky National Research Centre of Surgery

Lead sponsor

Source ClinicalTrials.gov